Acasti announces corporate name change to grace therapeutics, inc.

Name change reflects extensive scientific and corporate brand equity previously established under grace therapeutics grace therapeutics will begin trading on nasdaq under the trading symbol "grce" effective october 28, 2024 virtual key opinion leader event to be held on november 20 th princeton, n.j., oct. 25, 2024 (globe newswire) -- acasti pharma inc. (nasdaq: acst) (acasti or the company), a late-stage, biopharma company advancing gtx-104, its novel injectable formulation of nimodipine that addresses high unmet medical needs for a rare disease, aneurysmal subarachnoid hemorrhage (asah), today announced that it is changing its name to grace therapeutics, inc. (grace therapeutics).
ACST Ratings Summary
ACST Quant Ranking